| Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 V Monteil, H Kwon, P Prado, A Hagelkrüys, RA Wimmer, M Stahl, ... Cell 181 (4), 905-913. e7, 2020 | 2264 | 2020 |
| Real-time, portable genome sequencing for Ebola surveillance J Quick, NJ Loman, S Duraffour, JT Simpson, E Severi, L Cowley, JA Bore, ... Nature 530 (7589), 228-232, 2016 | 1489 | 2016 |
| Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients J Stebbing, V Krishnan, S de Bono, S Ottaviani, G Casalini, ... EMBO molecular medicine 12 (8), e12697, 2020 | 286 | 2020 |
| Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context P Mertens, N De Vos, D Martiny, C Jassoy, A Mirazimi, L Cuypers, ... Frontiers in medicine 7, 225, 2020 | 231 | 2020 |
| JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality J Stebbing, G Sánchez Nievas, M Falcone, S Youhanna, P Richardson, ... Science advances 7 (1), eabe4724, 2021 | 198 | 2021 |
| Genome-wide spatial expression profiling in formalin-fixed tissues EG Villacampa, L Larsson, R Mirzazadeh, L Kvastad, A Andersson, ... Cell Genomics 1 (3), 2021 | 117 | 2021 |
| Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection V Monteil, M Dyczynski, VM Lauschke, H Kwon, G Wirnsberger, ... EMBO molecular medicine 13 (1), e13426, 2021 | 113 | 2021 |
| Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2 Z Zheng, VM Monteil, S Maurer-Stroh, CW Yew, C Leong, NK Mohd-Ismail, ... Eurosurveillance 25 (28), 2000291, 2020 | 83 | 2020 |
| A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model DW Hawman, G Ahlén, KS Appelberg, K Meade-White, PW Hanley, ... Nature microbiology 6 (2), 187-195, 2021 | 61 | 2021 |
| Identification of lectin receptors for conserved SARS‐CoV‐2 glycosylation sites D Hoffmann, S Mereiter, Y Jin Oh, V Monteil, E Elder, R Zhu, D Canena, ... The EMBO Journal 40 (19), e108375, 2021 | 59 | 2021 |
| Emerging mosquito-borne threats and the response from European and Eastern Mediterranean countries N Johnson, M Fernández de Marco, A Giovannini, C Ippoliti, ML Danzetta, ... International Journal of Environmental Research and Public Health 15 (12), 2775, 2018 | 59 | 2018 |
| Self-priming of reverse transcriptase impairs strand-specific detection of dengue virus RNA A Tuiskunen, I Leparc-Goffart, L Boubis, V Monteil, J Klingstrom, HJ Tolou, ... Journal of general virology 91 (4), 1019-1027, 2010 | 55 | 2010 |
| A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells E Garreta, P Prado, ML Stanifer, V Monteil, A Marco, A Ullate-Agote, ... Cell Metabolism 34 (6), 857-873. e9, 2022 | 49 | 2022 |
| Methods of inactivation of highly pathogenic viruses for molecular, serology or vaccine development purposes S Elveborg, VM Monteil, A Mirazimi Pathogens 11 (2), 271, 2022 | 45 | 2022 |
| Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome A Tuiskunen, V Monteil, S Plumet, L Boubis, M Wahlström, V Duong, ... Archives of virology 156, 2023-2032, 2011 | 38 | 2011 |
| Genome-wide spatial expression profiling in formalin-fixed tissues. L Larsson, R Mirzazadeh, L Kvastad, A Andersson, A Mollbrink, ... Cell Genomics 1 (3), 100065-100065, 2021 | 37 | 2021 |
| Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants V Monteil, B Eaton, E Postnikova, M Murphy, B Braunsfeld, I Crozier, ... EMBO Molecular Medicine 14 (8), e15230, 2022 | 36 | 2022 |
| Serological and molecular study of Crimean-Congo hemorrhagic fever virus in cattle from selected districts in Uganda S Balinandi, C von Brömssen, A Tumusiime, J Kyondo, H Kwon, ... Journal of virological methods 290, 114075, 2021 | 34 | 2021 |
| Nucleoside-Modified mRNA Vaccines Protect IFNAR–/– Mice against Crimean-Congo Hemorrhagic Fever Virus Infection S Appelberg, L John, N Pardi, Á Végvári, S Bereczky, G Ahlén, V Monteil, ... Journal of Virology 96 (3), e01568-21, 2022 | 33 | 2022 |
| Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor T Capraz, NF Kienzl, E Laurent, JW Perthold, E Föderl-Höbenreich, ... Elife 10, e73641, 2021 | 30 | 2021 |
